Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,942
Total Claims
$1.4M
Drug Cost
575
Beneficiaries
$2,459
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-71%
Opioid rate vs peers
0.7% vs 2.6% avg
+130%
Cost per patient vs peers
$2,459 vs $1,068 avg
+64%
Brand preference vs peers
14.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.7%
Opioid Rate
66
Opioid Claims
$1,343
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,311 claims · $1.2M
Generic: 7,566 claims · $248K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 79 | $140K |
| Fluticasone/Umeclidin/Vilanter | 48 | $83K |
| Sitagliptin Phosphate | 53 | $71K |
| Apixaban | 46 | $58K |
| Mirabegron | 41 | $49K |
| Dapagliflozin Propanediol | 33 | $49K |
| Denosumab | 25 | $43K |
| Cariprazine Hcl | 17 | $39K |
| Semaglutide | 16 | $35K |
| Empagliflozin | 21 | $33K |
| Linaclotide | 26 | $31K |
| Evolocumab | 20 | $25K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $25K |
| Sitagliptin Phos/Metformin Hcl | 18 | $24K |
| Icosapent Ethyl | 35 | $21K |
Prescribing Profile
Patient Profile
72
Avg Age
49%
Female
1.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About